SciTech Development reports early-stage clinical data from Phase 1a trial of ST-001 nanoFenretinide at USCLC Annual Workshop 2026

Clarity Pharmaceuticals signs copper-64 manufacturing agreement with Theragenics

Merck to acquire Terns Pharmaceuticals for USD6.7bn

Maze Therapeutics reports positive Phase 2 data for MZE829 in patients with AMKD

Thermo Fisher Scientific and SHL Medical launch integrated US drug-device manufacturing

Myosin Therapeutics granted USD2m funding from Florida Department of Health

Clover Biopharmaceuticals reports positive US Phase I data for RSV re-vaccination in older adults

Akeso's Phase II trials of AK146D1 and AK138D1 approved in China

Sanofi and Regeneron's Dupixent gains Japan approval as first targeted therapy for bullous pemphigoid

Abbott completes Exact Sciences acquisition

UCB selects PANTHERx Rare to distribute KYGEVVI for TK2d

Roche launches new test to help clinicians treat patients with respiratory infections

GE HealthCare's Photonova Spectra gains FDA clearance

HUTCHMED launches Phase III trial of HMPL-760 for DLBCL in China

Pfizer and Valneva report strong Phase 3 results for Lyme disease vaccine candidate